| Filed On | Filing |
|---|---|
| 07 Aug 2026 |
8-K/A: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
This confirms our discussions relating to the end of your at-will employment with Tango Therapeutics, Inc. (“Tango” or the “Company”). The Company has elected to treat the ending of the relationship as a termination by the Company withou... |
Loading...